Lipoprotein-associated phospholipase A2 (Lp-PLA2), an enzyme produced and secreted by inflammatory cells, has the potential to be a novel target for the treatment of atherosclerosis [1–3] among other indications. This evidence concerns the gene PLA2G7 and atherosclerosis.